Exposure to pharmacists may shorten time to treatment intensification in T2D patients
Patients with type 2 diabetes (T2D) who are exposed to a pharmacist have a shorter time to treatment intensification and a greater decrease in A1C compared with those managed solely by a medical provider, according to a study. Results, however, are not statistically significant.